MedPath

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

Not Applicable
Active, not recruiting
Conditions
Asthma
Registration Number
NCT04448002
Lead Sponsor
University of Florida
Brief Summary

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
320
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Asthma Control using asthma control questionnaireChange in baseline, post-intervention,3 months, and 6 months, and 12 month follow-up

Measured via the Asthma Control Test questionnaire which has 5 items that assesses frequency of daytime and nocturnal asthma symptoms, activity limitations, and perceptions of disease control.Adolescents will complete all 5 items independently of caregivers. Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score \>19 indicates well-controlled asthma."

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

UF Health Pediatrics

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Nemours Children's Hospital

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

UF Health Pediatrics
πŸ‡ΊπŸ‡ΈGainesville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.